Kickstart your 2025 ADC development at 4th World ADC Asia Summit

Showcasing breakthrough R&D work, accelerating translation, and enhancing manufacturing efficiency to drive clinical validation of next-generation ADCs

2025-05-09     Korea Biomedical Review

Returning this June 10–12 at the Grand Hyatt Incheon in South Korea, the 4th World ADC Asia Summit is the most comprehensive platform for the fast-growing antibody-drug conjugate (ADC) community in Asia.

Following a successful 2024 edition, this year’s summit will cater for professionals at every stage of ADC development. With three tracks spanning discovery, preclinical & clinical development, and CMC, along with two focused seminar days on ADC fundamentals and bispecific ADCs. Whether you're new to the field or an established leader, the program offers valuable insights and networking opportunities for all.

“I’m thrilled to share new data and insights on next-generation ADCs with colleagues across the rapidly evolving Asia region.”

— Doo Young Jung, CEO, PinotBio (2025 Speaker)

With 40+ expert speakers representing global leaders including AstraZeneca, Daiichi Sankyo, top-tier Asian ADC biotechs, pioneering start-ups, and specialized service providers, the summit expects to welcome 300+ attendees. Participants will connect with trailblazing developers from China, Japan, Singapore, Taiwan, and beyond, alongside influential voices from the U.S. and Europe.

This is your chance to gain a holistic view of the ADC ecosystem in Asia - explore the latest in design innovation, emerging clinical data, and strategic partnerships that are shaping the next wave of therapeutic ADCs. The agenda is carefully curated to span the entire ADC lifecycle, including cutting-edge R&D, clinical validation, and region-specific regulatory pathways.

Key highlights Include:

   Poster Presentation Session – Present your research to a high-impact audience, boost your visibility, and engage with potential collaborators, investors, and decision-makers.

    Emerging ADC Formats – Learn how innovative targeting formats, payloads and linker designs are improving efficacy and target specificity.

   ● First-in-Human Data & Clinical Readouts – Stay ahead with updates from companies like Mythic Therapeutics and Immunwork.

Don’t miss your opportunity to stay at the forefront of ADC innovation and connect with the global leaders driving this exciting field forward.

For full details and registration, visit: https://ter.li/x7w1fy

Registration QR Code ↓

 

 

Related articles